hiPSCs derived SST-GABAergic interneuron progenitors (GABAeron)

N/A

Report date: 2025/03/20 15:08:27

Base Information

Drug NamehiPSCs derived SST-GABAergic interneuron progenitors (GABAeron)
Drug Alias NamehiPSCs derived somatostatin-GABAergic interneuron therapy (GABAeron)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGABAeron Inc
China Registration ClassN/A

Develop Information

Active CompaniesGABAeron Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A